Giant Biogene Holding Co. Ltd.

  • Market Cap: N/A
  • Industry: FMCG
  • ISIN: KYG3887G1091
HKD
35.10
0.74 (2.15%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
3,894.17
2,749.56
1,871.07
1,337.73
1,084.82
Other Operating Income
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,894.17
2,749.56
1,871.07
1,337.73
1,084.82
Raw Material Cost
637.59
429.34
257.13
220.78
193.82
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
Employee Cost
193.61
138.88
87.84
41.59
32.31
Power Cost
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.12
0.02
0.00
0.00
0.00
Selling and Distribution Expenses
1,393.58
950.59
486.66
198.04
127.18
Other Expenses
-11.09
-8.77
-6.14
-2.92
-2.02
Total Expenditure (Excl Depreciation)
2,114.01
1,431.14
770.23
431.19
333.14
Operating Profit (PBDIT) excl Other Income
1780.2
1318.4
1100.8
906.5
751.7
Other Income
115.10
61.53
57.69
15.41
28.68
Operating Profit (PBDIT)
1,933.80
1,411.52
1,181.99
943.13
799.22
Interest
0.12
0.02
0.00
0.00
0.00
Exceptional Items
32.41
-10.34
17.44
173.92
-11.29
Gross Profit (PBDT)
3,256.58
2,320.22
1,613.94
1,116.95
891.00
Depreciation
37.76
31.57
26.87
23.43
20.28
Profit Before Tax
1,928.32
1,369.58
1,172.57
1,093.63
767.66
Tax
328.06
204.86
174.50
164.91
115.45
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,604.18
1,165.23
998.07
928.68
626.22
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
Net Profit
1,604.18
1,165.23
998.07
928.68
626.22
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
Minority Interest
-3.92
-0.51
0.00
0.04
25.99
Other related items
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,600.26
1,164.72
998.07
928.72
652.21
Equity Capital
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
Reserves
4,802.74
3,181.25
1,243.80
543.03
1,283.81
Earnings per share (EPS)
1.64
0.83
1.0
0.93
0.63
Diluted Earnings per share
1.64
0.83
1.0
0.93
0.63
Operating Profit Margin (Excl OI)
45.73%
47.95%
58.65%
67.6%
69.16%
Gross Profit Margin
50.49%
50.96%
64.1%
83.5%
72.63%
PAT Margin
41.19%
42.38%
53.34%
69.42%
57.73%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2023 is 41.63% vs 46.95% in Dec 2022

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2023 is 37.40% vs 16.69% in Dec 2022

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2023 is 34.72% vs 20.07% in Dec 2022

stock-summary

Interest

YoY Growth in year ended Dec 2023 is 0.00% vs 0.00% in Dec 2022

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2023 has fallen from Dec 2022

Compare Annual Results Of Giant Biogene Holding Co. Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
3,894.17
17,401.97
-13,507.80
-77.62%
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,894.17
17,401.97
-13,507.80
-77.62%
Raw Material Cost
637.59
4,607.51
-3,969.92
-86.16%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
193.61
4,101.82
-3,908.21
-95.28%
Power Cost
0
0
0.00
Manufacturing Expenses
0.12
166.39
-166.27
-99.93%
Selling and Distribution Expenses
1,393.58
9,834.07
-8,440.49
-85.83%
Other Expenses
-11.09
-408.97
397.88
97.29%
Total Expenditure (Excl Depreciation)
2,114.01
14,620.09
-12,506.08
-85.54%
Operating Profit (PBDIT) excl Other Income
1,780.16
2,781.88
-1,001.72
-36.01%
Other Income
115.10
-124.19
239.29
192.68%
Operating Profit (PBDIT)
1,933.80
3,945.01
-2,011.21
-50.98%
Interest
0.12
166.39
-166.27
-99.93%
Exceptional Items
32.41
-891.82
924.23
103.63%
Gross Profit (PBDT)
3,256.58
12,794.46
-9,537.88
-74.55%
Depreciation
37.76
1,287.32
-1,249.56
-97.07%
Profit Before Tax
1,928.32
1,599.48
328.84
20.56%
Tax
328.06
500.73
-172.67
-34.48%
Provisions and contingencies
0
0.00
0.00
Profit After Tax
1,604.18
938.38
665.80
70.95%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,604.18
938.38
665.80
70.95%
Share in Profit of Associates
0
0.00
0.00
Minority Interest
-3.92
25.13
-29.05
-115.60%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,600.26
963.51
636.75
66.09%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
4,802.74
9,713.74
-4,911.00
-50.56%
Earnings per share (EPS)
1.64
0.64
1.00
156.25%
Diluted Earnings per share
1.64
0.64
1.00
156.25%
Operating Profit Margin (Excl OI)
45.73%
15.99%
0.00
29.74%
Gross Profit Margin
50.49%
16.59%
0.00
33.90%
PAT Margin
41.19%
5.39%
0.00
35.80%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 389.42 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 41.63% vs 46.95% in Dec 2022

Annual - Consolidate Net Profit
Consolidate Net Profit 160.03 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 37.40% vs 16.69% in Dec 2022

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 181.87 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 34.72% vs 20.07% in Dec 2022

Annual - Interest
Interest 0.01 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 0.00% vs 0.00% in Dec 2022

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 45.73%
in Dec 2023

Figures in %
stock-summary

YoY Growth in year ended Dec 2023 has fallen from Dec 2022